Therefore, the aim of the present study was to compare the effect of high-dose metformin treatment on circulating prolactin levels in hyperprolactinemic women with classic PCOS and without this disorder, and to assess whether metformin action on lactotrope secretory function in women is modulated by androgen status. This evidence concerns the gene PRL and polycystic ovary syndrome.